S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

AMLX Amylyx Pharmaceuticals Inc

3.35

-0.01 (-0.30%)

Pre Market

Last Updated: 23:03:49

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Amylyx Pharmaceuticals (NASDAQ:AMLX)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Amylyx Pharmaceuticals Charts.

Amylyx Pharmaceuticals (NASDAQ:AMLX)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Amylyx Pharmaceuticals Charts.

Amylyx Pharmaceuticals Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 March 2025 (15 hours ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 March 2025 (15 hours ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 March 2025 (15 hours ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Wednesday 5 March 2025 (2 days ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Tuesday 4 March 2025 (2 days ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Tuesday 4 March 2025 (2 days ago) • Edgar (US Regulatory)

Form POSASR - Post-effective Amendment to an automatic shelf registration statement
Tuesday 4 March 2025 (2 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 4 March 2025 (2 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 27 February 2025 (1 week ago) • Edgar (US Regulatory)

Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences
Wednesday 26 February 2025 (1 week ago) • Business Wire

Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
Tuesday 25 February 2025 (1 week ago) • Business Wire

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Saturday 15 February 2025 (3 weeks ago) • Edgar (US Regulatory)

More Amylyx Pharmaceuticals Inc News Articles

Newcrest Mining

National Australia Bank

AUD vs US Dollar

Australia And New Zealan...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions